Literature DB >> 31427355

Associations among gastroesophageal reflux disease, mental disorders, sleep and chronic temporomandibular disorder: a case-control study.

Yuanyuan Li1, Ming Fang1, Lina Niu1, Yu Fan1, Yan Liu1, Yong Long1, Xiaodong Liu1, Franklin R Tay1, Jihua Chen2.   

Abstract

BACKGROUND: Temporomandibular disorders (TMDs) are a family of pain-related disorders associated with impaired function in the jaw, temporomandibular joint and muscles of mastication. Our objectives were to evaluate the association between chronic TMD and gastresophageal reflux disease (GERD) and to determine whether mental disorders or undermined sleep mediates this association.
METHODS: We conducted a case-control study involving 1522 consecutive adult patients with chronic TMD and 1522 matched controls from 2 hospitals in China. All participants were aged between 18 and 70 years and were recruited from July 2017 to April 2018 Chronic TMD was diagnosed by trained dentists using the criteria in the Orofacial Pain Prospective Evaluation and Risk Assessment Study. Trained gastroenterologists made blinded diagnoses of GERD according to the Montreal definition and classification (at least 2 d of mild symptoms, or 1 d of moderate or severe symptoms per week). We used validated questionnaires to evaluate psychological status and sleep quality.
RESULTS: Of the study participants, we identified 132 patients and 61 controls with GERD. Using conditional logistic regression analysis, we identified GERD as a risk factor for TMD (odds ratio 2.74, 95% confidence interval 1.88 to 3.98). Mediation analyses identified that somatization, anxiety and undermined sleep moderately mediated the relation between TMD and GERD.
INTERPRETATION: Our study suggests that symptomatic GERD is associated with chronic, painful TMD, and somatization, anxiety and undermined sleep mediate this association to a certain extent. Due consideration should be given to the evaluation and management of gastrointestinal symptoms and mental disorders in the combined therapy for painful TMD.
© 2019 Joule Inc. or its licensors.

Entities:  

Mesh:

Year:  2019        PMID: 31427355      PMCID: PMC6699946          DOI: 10.1503/cmaj.181535

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  40 in total

1.  Compared to what? Finding controls for case-control studies.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

2.  Selection of controls in case-control studies. I. Principles.

Authors:  S Wacholder; J K McLaughlin; D T Silverman; J S Mandel
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

3.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

4.  The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Psychosom Med       Date:  2002 Mar-Apr       Impact factor: 4.312

Review 5.  Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Authors:  William E Whitehead; Olafur Palsson; Kenneth R Jones
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

6.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

7.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

8.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

9.  Prevalence of temporomandibular disorder subtypes, psychologic distress, and psychosocial dysfunction in Asian patients.

Authors:  Adrian U J Yap; Samuel F Dworkin; E K Chua; Thomas List; Keson B C Tan; H H Tan
Journal:  J Orofac Pain       Date:  2003

10.  Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.

Authors:  H-K Jung; S Halder; M McNally; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2007-08-01       Impact factor: 8.171

View more
  5 in total

1.  Gastroesophageal reflux disease, temporomandibular disorders and dysfunctional breathing.

Authors:  Jim R Bartley
Journal:  CMAJ       Date:  2019-11-11       Impact factor: 8.262

Review 2.  Eating disorders through the periodontal lens.

Authors:  Hélène Rangé; Pierre Colon; Nathalie Godart; Yvonne Kapila; Philippe Bouchard
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 12.239

Review 3.  Clinical manifestations of gastrointestinal diseases in the oral cavity.

Authors:  Mohammad S Al-Zahrani; Ahmed A Alhassani; Khalid H Zawawi
Journal:  Saudi Dent J       Date:  2021-09-13

Review 4.  Impact of the COVID-19 Pandemic on Stress, Sleep, and Oral Health in University Students.

Authors:  Thaissa Reis do Carmo Cerqueira; Sayene Garcia Batista; Elson Braga de Mello; Marcos Fabio DosSantos; Inger Teixeira de Campos Tuñas
Journal:  Front Pain Res (Lausanne)       Date:  2021-10-26

5.  The Prevalence and Predicting Factors of Temporomandibular Disorders in COVID-19 Infection: A Cross-Sectional Study.

Authors:  Camille Haddad; Suzanna Maria Sayegh; Amine El Zoghbi; Ghida Lawand; Lara Nasr
Journal:  Cureus       Date:  2022-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.